Suppr超能文献

钙蛋白酶3是骨骼肌中dysferlin蛋白复合物的调节剂。

Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.

作者信息

Huang Yanchao, de Morrée Antoine, van Remoortere Alexandra, Bushby Kate, Frants Rune R, den Dunnen Johan T, van der Maarel Silvère M

机构信息

Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Hum Mol Genet. 2008 Jun 15;17(12):1855-66. doi: 10.1093/hmg/ddn081. Epub 2008 Mar 11.

Abstract

Muscular dystrophies comprise a genetically heterogeneous group of degenerative muscle disorders characterized by progressive muscle wasting and weakness. Two forms of limb-girdle muscular dystrophy, 2A and 2B, are caused by mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively. While CAPN3 may be involved in sarcomere remodeling, DYSF is proposed to play a role in membrane repair. The coexistence of CAPN3 and AHNAK, a protein involved in subsarcolemmal cytoarchitecture and membrane repair, in the dysferlin protein complex and the presence of proteolytic cleavage fragments of AHNAK in skeletal muscle led us to investigate whether AHNAK can act as substrate for CAPN3. We here demonstrate that AHNAK is cleaved by CAPN3 and show that AHNAK is lost in cells expressing active CAPN3. Conversely, AHNAK accumulates when calpain 3 is defective in skeletal muscle of calpainopathy patients. Moreover, we demonstrate that AHNAK fragments cleaved by CAPN3 have lost their affinity for dysferlin. Thus, our findings suggest interconnectivity between both diseases by revealing a novel physiological role for CAPN3 in regulating the dysferlin protein complex.

摘要

肌营养不良症是一组具有遗传异质性的退行性肌肉疾病,其特征为进行性肌肉萎缩和无力。肢带型肌营养不良症的两种类型,即2A和2B型,分别由钙蛋白酶3(CAPN3)和dysferlin(DYSF)的突变引起。虽然CAPN3可能参与肌节重塑,但有人提出DYSF在膜修复中发挥作用。CAPN3与AHNAK(一种参与肌膜下细胞结构和膜修复的蛋白质)在dysferlin蛋白复合物中共存,以及骨骼肌中存在AHNAK的蛋白水解裂解片段,这促使我们研究AHNAK是否可作为CAPN3的底物。我们在此证明AHNAK可被CAPN3裂解,并表明在表达活性CAPN3的细胞中AHNAK会缺失。相反,在钙蛋白酶病患者的骨骼肌中,当钙蛋白酶3有缺陷时,AHNAK会积累。此外,我们证明被CAPN3裂解的AHNAK片段对dysferlin失去了亲和力。因此,我们的研究结果通过揭示CAPN3在调节dysferlin蛋白复合物中的新生理作用,表明了这两种疾病之间的相互联系。

相似文献

1
Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.
Hum Mol Genet. 2008 Jun 15;17(12):1855-66. doi: 10.1093/hmg/ddn081. Epub 2008 Mar 11.
3
Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.
J Muscle Res Cell Motil. 2011 Dec;32(4-5):271-80. doi: 10.1007/s10974-011-9271-8. Epub 2011 Nov 5.
5
Reverse engineering gene network identifies new dysferlin-interacting proteins.
J Biol Chem. 2011 Feb 18;286(7):5404-13. doi: 10.1074/jbc.M110.173559. Epub 2010 Nov 30.
6
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol. 2013 Aug;45(8):1927-38. doi: 10.1016/j.biocel.2013.06.007. Epub 2013 Jun 19.
7
Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy.
J Mol Neurosci. 2019 Dec;69(4):563-569. doi: 10.1007/s12031-019-01383-z. Epub 2019 Aug 13.
8
A muscle-specific calpain, CAPN3, forms a homotrimer.
Biochim Biophys Acta Proteins Proteom. 2020 Jul;1868(7):140411. doi: 10.1016/j.bbapap.2020.140411. Epub 2020 Mar 19.
9
Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles.
J Mol Biol. 2011 Apr 1;407(3):439-49. doi: 10.1016/j.jmb.2011.01.057. Epub 2011 Feb 3.

引用本文的文献

1
Muscular Dystrophies.
Adv Exp Med Biol. 2025;1478:245-284. doi: 10.1007/978-3-031-88361-3_11.
2
In situ detection of activation of CAPN3, a responsible gene product for LGMDR1, in mouse skeletal myotubes.
J Biol Chem. 2025 Jun;301(6):108536. doi: 10.1016/j.jbc.2025.108536. Epub 2025 Apr 23.
3
Case report: A single novel calpain 3 gene variant associated with mild myopathy.
Front Genet. 2024 Dec 5;15:1437859. doi: 10.3389/fgene.2024.1437859. eCollection 2024.
4
A retrospective study on the clinical and molecular outcomes of calpainopathy in a Turkish patient cohort.
Turk J Med Sci. 2023 Dec 18;54(1):86-98. doi: 10.55730/1300-0144.5769. eCollection 2024.
6
Novel Biomarkers for Limb Girdle Muscular Dystrophy (LGMD).
Cells. 2024 Feb 10;13(4):329. doi: 10.3390/cells13040329.
8
AHNAKs roles in physiology and malignant tumors.
Front Oncol. 2023 Nov 14;13:1258951. doi: 10.3389/fonc.2023.1258951. eCollection 2023.
9
Altered expression of proteins involved in metabolism in LGMDR1 muscle is lost in cell culture conditions.
Orphanet J Rare Dis. 2023 Oct 10;18(1):315. doi: 10.1186/s13023-023-02873-5.
10
Portrait of Dysferlinopathy: Diagnosis and Development of Therapy.
J Clin Med. 2023 Sep 16;12(18):6011. doi: 10.3390/jcm12186011.

本文引用的文献

1
Fetuin A stabilizes m-calpain and facilitates plasma membrane repair.
J Biol Chem. 2007 Dec 7;282(49):35868-77. doi: 10.1074/jbc.M706929200. Epub 2007 Oct 17.
3
Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane.
J Biol Chem. 2007 Jan 26;282(4):2567-75. doi: 10.1074/jbc.M604560200. Epub 2006 Nov 22.
4
Identification of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer.
J Biol Chem. 2006 Nov 17;281(46):35030-8. doi: 10.1074/jbc.M606545200. Epub 2006 Sep 19.
5
Calpain 3: a key regulator of the sarcomere?
FEBS J. 2006 Aug;273(15):3427-36. doi: 10.1111/j.1742-4658.2006.05351.x.
7
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.
J Med Genet. 2005 Sep;42(9):686-93. doi: 10.1136/jmg.2004.028738.
8
Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway.
Hum Mol Genet. 2005 Aug 1;14(15):2125-34. doi: 10.1093/hmg/ddi217. Epub 2005 Jun 16.
10
Specific AHNAK expression in brain endothelial cells with barrier properties.
J Cell Physiol. 2005 May;203(2):362-71. doi: 10.1002/jcp.20232.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验